COMMUNIQUÉ DE PRESSE publié le 08/01/2024 à 19:00, il y a 1 année 10 mois City Innovate Announces Selection by AFWERX for SBIR Phase 1 City Innovate has been selected by AFWERX for an SBIR Phase 1, focused on automating the development of complex RFP packages for the Department of the Air Force. This AI-powered tool, trained on 12+ million government RFPs, aims to revolutionize government procurement with Generative AI, significantly enhancing the efficiency and effectiveness of the Air Force's operations. City Innovate Generative AI AFWERX SBIR Phase 1 Government Procurement
COMMUNIQUÉ DE PRESSE publié le 03/01/2024 à 19:00, il y a 1 année 11 mois City Innovate Recognized by GovTech 100 as Top Government Agency Solution Provider City Innovate has been recognized on the GovTech 100 list for its pioneering Document Process Automation (DPA) platform, which accelerates the time to value of complex documents for state and local governments. The platform ensures compliance, insight, and visibility, enabling governments to serve their residents more effectively. Through innovative solutions, City Innovate aims to transform government operations and drive impactful decision-making by streamlining processes and ensuring efficiency. The company continues to expand its solution portfolio and partners with major agencies, processing over $15Bn in critical goods and services, while also introducing the industry-leading GenAI module to revolutionize government operations around document creation. City Innovate Document Process Automation GovTech 100 Government Technology Compliance And Efficiency
Publié le 04/12/2025 à 18:14, il y a 13 heures 40 minutes Résiliation d'une convention conclue entre actionnaires
Publié le 04/12/2025 à 18:00, il y a 13 heures 55 minutes Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Publié le 04/12/2025 à 18:00, il y a 13 heures 55 minutes Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Publié le 04/12/2025 à 17:45, il y a 14 heures 10 minutes Informations relatives au nombre total de droits de vote et d’actions
Publié le 04/12/2025 à 17:45, il y a 14 heures 10 minutes MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Publié le 05/12/2025 à 02:35, il y a 5 heures 20 minutes Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Publié le 05/12/2025 à 01:00, il y a 6 heures 55 minutes BEACN Closes First Tranche of Non-Brokered Private Placement
Publié le 04/12/2025 à 23:05, il y a 8 heures 50 minutes BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Publié le 04/12/2025 à 23:00, il y a 8 heures 55 minutes NXT Energy Solutions Completes Data Acquisition for SFD Survey
Publié le 05/12/2025 à 07:00, il y a 55 minutes Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Publié le 05/12/2025 à 03:30, il y a 4 heures 24 minutes CGTN: What makes cooperation between China and France a two-way success
Publié le 04/12/2025 à 23:50, il y a 8 heures 4 minutes EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Publié le 04/12/2025 à 20:25, il y a 11 heures 29 minutes Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Publié le 04/12/2025 à 20:15, il y a 11 heures 40 minutes Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025